Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAGE-FREE II
NCT04971356Active, not recruiting
- Sponsor
- Xijing Hospital
- Start
- Nov 2021
- Primary completion
- Mar 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised trial of aspirin and ticagrelor in acute coronary syndrome (ACS) (2 arms), sponsored by Xijing Hospital. Primary endpoint: Net adverse clinical events at 12 months. Started Nov 2021; status: active, not recruiting.
02
Drugs
aspirinticagrelor
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT04971356.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04971356.